IN2014DN05769A - - Google Patents

Info

Publication number
IN2014DN05769A
IN2014DN05769A IN5769DEN2014A IN2014DN05769A IN 2014DN05769 A IN2014DN05769 A IN 2014DN05769A IN 5769DEN2014 A IN5769DEN2014 A IN 5769DEN2014A IN 2014DN05769 A IN2014DN05769 A IN 2014DN05769A
Authority
IN
India
Prior art keywords
hippocampus
present
regenerating
mammal
defective
Prior art date
Application number
Inventor
Angel Lopez
Quenten Schwarz
Original Assignee
Medvet Science Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011905180A external-priority patent/AU2011905180A0/en
Application filed by Medvet Science Pty Ltd filed Critical Medvet Science Pty Ltd
Publication of IN2014DN05769A publication Critical patent/IN2014DN05769A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells

Abstract

The present invention relates generally to a method of regenerating the hippocampus in a mammal and agents for use therein. More particularly the present invention provides a method of regenerating the hippocampus in a mammal by administering a sub population of neural crest stem cells. The method of the present invention is useful in the treatment of conditions characterised by a defective hippocampus such as neuropsychiatric disorders.
IN5769DEN2014 2011-12-13 2012-12-13 IN2014DN05769A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2011905180A AU2011905180A0 (en) 2011-12-13 Method of treatment
PCT/AU2012/001530 WO2013086574A1 (en) 2011-12-13 2012-12-13 Method of treatment

Publications (1)

Publication Number Publication Date
IN2014DN05769A true IN2014DN05769A (en) 2015-04-10

Family

ID=48611719

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5769DEN2014 IN2014DN05769A (en) 2011-12-13 2012-12-13

Country Status (9)

Country Link
US (1) US20140348793A1 (en)
EP (1) EP2791324B1 (en)
JP (1) JP2015500297A (en)
KR (1) KR20140116103A (en)
CN (1) CN104540938A (en)
AU (1) AU2012350357A1 (en)
CA (1) CA2859213A1 (en)
IN (1) IN2014DN05769A (en)
WO (1) WO2013086574A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022006404A1 (en) * 2020-07-02 2022-01-06 The Johns Hopkins University Fmri-hippocampus acoustic battery (fhab)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030003572A1 (en) * 1999-03-05 2003-01-02 David J. Anderson Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression
ITNA20060017A1 (en) * 2006-02-20 2007-08-21 Aquino Riccardo D TECHNIQUE OF COLLECTION AND SELECTION OF AN EMBRYONIC-TYPE POPLATION OF STEM CELLS FROM PERIDENT FOLLICULAR FABRICS OF ADULT MEN.
CA2883922C (en) * 2010-02-03 2019-08-27 Samsung Life Public Welfare Foundation Method for proliferating stem cells by activating notch signaling
EP2758778B1 (en) * 2011-09-22 2019-07-03 Precision Medicine Holdings Pty Ltd Screening method

Also Published As

Publication number Publication date
EP2791324A1 (en) 2014-10-22
KR20140116103A (en) 2014-10-01
CA2859213A1 (en) 2013-06-20
EP2791324A4 (en) 2015-04-29
EP2791324B1 (en) 2017-05-10
JP2015500297A (en) 2015-01-05
US20140348793A1 (en) 2014-11-27
WO2013086574A1 (en) 2013-06-20
AU2012350357A1 (en) 2014-07-24
CN104540938A (en) 2015-04-22

Similar Documents

Publication Publication Date Title
AR121843A2 (en) OPHTHALMIC FORMULATION AND METHOD TO IMPROVE PRESBYOPIA
MX2016005159A (en) Methods of diagnosing and treating eosinophilic disorders.
MX2012001310A (en) Methods for providing beneficial effects to the oral cavity.
GB2503852A (en) Compounds for the treatment of neuropsychiatric disorders
CO7240407A2 (en) Crystal forms of an androgenic receptor modulator
MX338535B (en) Ibat inhibitors for the treatment of liver diseases.
IN2014DN06710A (en)
MX2014000578A (en) Treatment with anti-pcsk9 antibodies.
MY194587A (en) Composition and method for the diagnosis and treatment of diseases associated with neurite degeneration
MY188365A (en) Diagnosis and treatments relating to th2 inhibition
MX2013008192A (en) Bace-2 inhibitors for the treatment of metabolic disorders.
MX355606B (en) Methods for diagnosing and treating eye-length related disorders.
MX2014000515A (en) Methods for treating inflammation and hypertension with gamma-ketoaldehyde skavengers.
MX2012013740A (en) Methods for treating methotrexate-resistant disorders with 10-propargyl-10-deazaaminopterin.
MX2018008882A (en) Composition and method for the diagnosis and treatment of iron-related disorders.
EA201490614A1 (en) TREATMENT OF DISEASES AND DISTURBANCES CAUSED BY ACTIVITY OF NF-kB TRANSCRIPTION FACTOR
NZ624726A (en) Methods for treating gout flares
MX2015001488A (en) Treating inflammation using serelaxin.
IN2015DN01137A (en)
AU2016219603A1 (en) Method of treating the effects of stroke
MX356933B (en) Composition and method for the diagnosis and treatment of iron-related disorders.
MX2012014163A (en) Methods of treatment.
SG195127A1 (en) Methods of treating or preventing neurological diseases
MX356317B (en) Treatment of symptoms associated with female gastroparesis.
TR201900438T4 (en) Non-acylated ghrelin fragments for use in the treatment of Prader-willi syndrome.